Penserra Capital Management’s Transmedics TMDX Stock Holding History

Penserra Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$199K	Sell	2,010 -4,273	-68%	-$557K	﹤0.01%	672
2025 Q4	$764K	Buy	+6,283	New	+$788K	0.01%	485
2025 Q3	–	Sell	-18,090	Closed	-$2.42M	–	1092
2025 Q2	$2.42M	Buy	+18,090	New	+$1.99M	0.03%	316
2024 Q3	–	Sell	-21,391	Closed	-$3.22M	–	1314
2024 Q2	$3.22M	Buy	+21,391	New	+$2.57M	0.04%	295
2023 Q3	–	Sell	-38,846	Closed	-$3.26M	–	1373
2023 Q2	$3.26M	Buy	+38,846	New	+$2.97M	0.06%	223

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Penserra Capital Management's TMDX Position: Q1 2026 in Review

Penserra Capital Management reduced its Transmedics (TMDX) stake by 68% in Q1 2026, selling an estimated $557K and leaving 2,010 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #672.

Penserra Capital Management first reported a position in TMDX in Q2 2023 and has held it in 5 quarters since. The position peaked at $3.26M in Q2 2023. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Penserra Capital Management held 2,010 shares of Transmedics worth $199K as of Q1 2026.
Penserra Capital Management sold 4,273 Transmedics shares in Q1 2026, an estimated $557K.
Transmedics made up ﹤0.01% of Penserra Capital Management's portfolio in Q1 2026, its #672 holding.
Penserra Capital Management first reported a position in Transmedics in Q2 2023 and has held it in 5 quarters since.
Penserra Capital Management's Transmedics position peaked at $3.26M in Q2 2023.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Penserra Capital Management's 13F filing for Q1 2026, filed 11 May 2026.